...
首页> 外文期刊>EJNMMI Research >No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT
【24h】

No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT

机译:使用[123I] FP-CIT(DaTSCAN)和SPECT的吸烟者,前吸烟者和非吸烟者之间的纹状体多巴胺转运蛋白可用性无差异

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Mesolimbic and nigrostriatal dopaminergic pathways play important roles in both the rewarding and conditioning effects of drugs. The dopamine transporter (DAT) is of central importance in regulating dopaminergic neurotransmission and in particular in activating the striatal D2-like receptors. Molecular imaging studies of the relationship between DAT availability/dopamine synthesis capacity and active cigarette smoking have shown conflicting results. Through the collaboration between 13 SPECT centres located in 10 different European countries, a database of FP-CIT-binding in healthy controls was established. We used the database to test the hypothesis that striatal DAT availability is changed in active smokers compared to non-smokers and ex-smokers. Methods A total of 129 healthy volunteers were included. Subjects were divided into three categories according to past and present tobacco smoking: (1) non-smokers (n = 64), (2) ex-smokers (n = 39) and (3) active smokers (n = 26). For imaging of the DAT availability, we used [123I]FP-CIT (DaTSCAN) and single photon emission computed tomography (SPECT). Data were collected in collaboration between 13 SPECT centres located in 10 different European countries. The striatal measure of DAT availability was analyzed in a multiple regression model with age, SPECT centre and smoking as predictor. Results There was no statistically significant difference in DAT availability between the groups of active smokers, ex-smokers and non-smokers (p = 0.34). Further, we could not demonstrate a significant association between striatal DAT and the number of cigarettes per day or total lifetime cigarette packages in smokers and ex-smokers. Conclusion Our results do not support the hypothesis that large differences in striatal DAT availability are present in smokers compared to ex-smokers and healthy volunteers with no history of smoking.
机译:背景中脑边缘和黑质纹状体多巴胺能途径在药物的奖励和调节作用中都起着重要作用。多巴胺转运蛋白(DAT)在调节多巴胺能神经传递中,特别是在激活纹状体D2样受体方面具有至关重要的作用。 DAT可用性/多巴胺合成能力与主动吸烟之间关系的分子成像研究显示出相互矛盾的结果。通过位于欧洲10个不同国家的13个SPECT中心之间的合作,建立了健康对照中FP-CIT结合的数据库。我们使用该数据库来检验以下假设:活跃吸烟者与不吸烟者和前吸烟者相比,纹状体DAT可用性发生了变化。方法纳入129名健康志愿者。根据过去和现在的吸烟状况,将受试者分为三类:(1)不吸烟者(n = 64),(2)前吸烟者(n = 39)和(3)积极吸烟者(n = 26)。对于DAT可用性的成像,我们使用了[123I] FP-CIT(DaTSCAN)和单光子发射计算机断层扫描(SPECT)。位于欧洲10个不同国家的13个SPECT中心之间合作收集了数据。在年龄,SPECT中心和吸烟为预测因子的多元回归模型中分析了DAT可用性的纹状体测量。结果积极吸烟者,前吸烟者和不吸烟者之间的DAT可用性在统计学上无显着差异(p = 0.34)。此外,我们无法证明纹状体DAT与每天吸烟的人数或吸烟者和前吸烟者的终生香烟包装之间的显着相关性。结论我们的结果不支持以下假设:吸烟者与无吸烟史的前吸烟者和健康志愿者相比,纹状体DAT可用性存在较大差异。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号